Anti-phosphoenolpyruvate carboxykinase 2 antibody in patients with autoimmune hepatitis

Hepatology Research

Volumn 44, Issue 9, 2014, Pages 1019-1025

  Kanno, Yukiko ^a   Watanabe, Hiroshi ^a   Takahashi, Atsushi ^a   Abe, Kazumichi ^a   Ohira, Hiromasa ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Autoantibody; Autoimmune hepatitis; Non alcoholic steatohepatitis; Phosphoenolpyruvate carboxykinase 2; Primary biliary cirrhosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ENZYME ANTIBODY; IMMUNOGLOBULIN G; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP) 2 ANTIBODY; UNCLASSIFIED DRUG;

ACUTE HEPATITIS; ADULT; AGED; AMINO TERMINAL SEQUENCE; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; AUTOIMMUNE HEPATITIS; CHRONIC HEPATITIS C; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; HUMAN CELL; INCIDENCE; LIVER CIRRHOSIS; MALE; NONALCOHOLIC FATTY LIVER; PREVALENCE; PRIMARY BILIARY CIRRHOSIS; SENSITIVITY AND SPECIFICITY; SYSTEMIC LUPUS ERYTHEMATOSUS; TOXIC HEPATITIS; VERY ELDERLY;

EID: 84907867483     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/hepr.12276     Document Type: Article

References (30)

1. Czaja AJ. Current concepts of autoimmune hepatitis. Ann Hepatol 2005; 4: 6-24.
2. Ohira H, Takahashi A. Current trends in the diagnosis and treatment of autoimmune hepatitis in Japan. Hepatol Res 2012; 42: 131-138.
3. Takahashi H, Zeniya M. Acute presentation of autoimmune hepatitis: does it exist? A published work review. Hepatol Res 2011; 41: 498-504.
4. Abe M, Mashiba T, Zeniya M etal. Autoimmune Hepatitis Study Group-Subgroup of the Intractable Hepato-Biliary Disease Study Group in Japan. Present status of autoimmune hepatitis in Japan: a nationwide survey. J Gastroenterol 2011; 46: 1136-1141.
5. Oketani M, Ido A, Nakayama N etal. Etiology and prognosis of fulminant hepatitis and late-onset hepatic failure in Japan: summary of the annual nationwide survey between 2004 and 2009. Hepatol Res 2013; 43: 97-105.
6. Czaja AJ, Manns MP. Advances in the diagnosis, pathogenesis, and management of autoimmune hepatitis. Gastroenterology 2010; 139: 58-72.
7. Oo YH, Hubscher SG, Adams DH. Autoimmune hepatitis: new paradigms in the pathogenesis, diagnosis, and management. Hepatol Int 2010; 4: 475-493.
8. Krawitt EL. Autoimmune hepatitis. N Engl J Med 2006; 354: 54-66.
9. Herkel J, Manns MP, Lohse AW. Selenocysteine, soluble liver antigen/liver-pancreas, and autoimmune hepatitis. Hepatology 2007; 46: 275-277.
10. Alvarez F, Berg PA, Bianchi FB etal. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31: 929-938.
11. Kaplan MM, Gershwin ME. Primary biliary cirrhosis. New Engl. J Med 2005; 353: 1261-1273.
12. McFarlane BM, McSorley CG, Vergani D etal. Serum autoantibodies reacting with the hepatic asialoglycoprotein receptor protein (hepatic lectin) in acute and chronic liver disorders. J Hepatol 1986; 3: 196-205.
13. Vergani D, Alvarez F, Bianchi FB etal. Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group. J Hepatol 2004; 41: 677-683.
14. Zamanou A, Tsirogianni A, Terzoglou C, Balafas A, Economidou I, Lymberi P. Anti-smooth muscle antibodies (ASMAs) and anti-cytoskeleton antibodies (ACTAs) in liver diseases: a comparison of classical indirect immunofluorescence with ELISA. J Clin Lab Anal 2002; 16: 194-201.
15. Fusconi M, Cassani F, Zauli D etal. Anti-actin antibodies: a new test for an old problem. J Immunol Methods 1990; 130: 1-8.
16. Czaja AJ, Cassani F, Cataleta M, Valentini P, Bianchi FB. Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis. Hepatology 1996; 24: 1068-1073.
17. Ma Y, Okamoto M, Thomas MG etal. Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease. Hepatology 2002; 35: 658-664.
18. Kanzler S, Weidemann C, Gerken G etal. Clinical significance of autoantibodies to soluble liver antigen in autoimmune hepatitis. J Hepatol 1999; 31: 635-640.
19. Czaja AJ, Shums Z, Norman GL. Frequency and significance of antibodies to soluble liver antigen/liver pancreas in variant autoimmune hepatitis. Autoimmunity 2002; 35: 475-483.
20. Baeres M, Daehnrich C, Schlumberger W etal. Establishment of standardised SLA/LP immunoassays: specificity for autoimmune hepatitis, worldwide occurrence, and clinical characteristics. Gut 2002; 51: 259-264.
21. Miyakawa H, Kawashima Y, Kitazawa E etal. Low frequency of anti-SLA/LP autoantibody in Japanese adult patients with autoimmune liver diseases: analysis with recombinant antigen assay. J Autoimmun 2003; 21: 77-82.
22. Treichel U, McFarlane BM, Seki T etal. Demographics of anti-asialoglycoprotein receptor autoantibodies in autoimmune hepatitis. Gastroenterology 1994; 107: 799-804.
23. Husa P, Chalupa P, Stroblová H etal. Autoantibodies to asialoglycoprotein receptor in chronic hepatitis C patients. Acta Virol 2001; 45: 7-11.
24. Radziuk J, Pye S. Hepatic glucose uptake, gluconeogenesis and the regulation of glycogen synthesis. Diabetes Metab Res Rev 2001; 17: 250-272.
25. Watford M, Hod Y, Chiao YB etal. The unique role of the kidney in gluconeogenesis in the chicken. The significance of a cytosolic form of phosphoenolpyruvate carboxykinase. J Biol Chem 1981; 256: 10023-10027.
26. Hommes FA, Bendien K, Elema JD etal. Two cases of phosphoenolpyruvate carboxykinase deficiency. Acta Paediatr Scand 1976; 65: 233-240.
27. Clayton PT, Hyland K, Brand M etal. Mitochondrial phosphoenolpyruvate carboxykinase deficiency. Eur J Pediatr 1986; 145: 46-50.
28. Yatsuji S, Hashimoto E, Kaneda H etal. Diagnosing autoimmune hepatitis in nonalcoholic fatty liver disease: is the International Autoimmune Hepatitis Group scoring system useful? J Gastroenterol 2005; 40: 1130-1138.
29. Loria P, Lonardo A, Leonardi F etal. Non-organ-specific autoantibodies in nonalcoholic fatty liver disease: prevalence and correlates. Dig Dis Sci 2003; 48: 2173-2181.
30. Fukuda S, Komori A, Itoh M etal. Histological remission during corticosteroid therapy of overlapping nonalcoholic steatohepatitis and autoimmune hepatitis: case report and literature review. Case Rep Gastroenterol 2011; 5: 553-557.